Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7396841
(Pediatric) | TAKEDA PHARMS NA | Injections |
Feb, 2022
(1 year, 1 month ago) |
Drugs and Companies using LANSOPRAZOLE ingredient
Market Authorisation Date: 27 May, 2004
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic